Xeno Biosciences Inc. — Form D
Xeno Biosciences Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2019-02-08. The offering totals $1.6M, of which $720K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2019-02-08
- Form: D
- Accession: 0001748206-19-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.6M
- Amount sold: $720K
- Remaining: $880K
- Investors: 21
- Date of first sale: 2019-02-01
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-332487
Issuer
- Name: Xeno Biosciences Inc.
- CIK: 0001748206
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 1770 Massachusetts Avenue, Suite 224, CAMBRIDGE, MA, 02140
- Phone: 833-807-3142
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Hasan Celiker | Director | Somerville, MA |
| Hasan Celiker | Executive Officer | Somerville, MA |
| Jeffrey Arnold | Director | Newton, MA |
| David Beno | Director | CAMBRIDGE, MA |
| David Beno | Executive Officer | CAMBRIDGE, MA |
| Michael Koeris | Director | CAMBRIDGE, MA |
| Tom Hughes | Director | CAMBRIDGE, MA |
| Stan Rose | Director | CAMBRIDGE, MA |
Other filings by this issuer (3)
More